Cortical Cholinergic Transmission and Cortical Information Processing in Schizophrenia
The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
Abstract
Models of the neuronal mediation of psychotic symptoms traditionally have focused on aberrations in the regulation of mesolimbic dopaminergic neurons, via their telencephalic afferent connections, and on the impact of abnormal mesolimbic activity for functions of the ventral striatum and its pallidal-thalamic-cortical efferent circuitry. Repeated psychostimulant exposure models major aspects of the sensitized activity of ventral striatal dopaminergic transmission that is observed in patients exhibiting psychotic symptoms. Based on neuroanatomical, neurochemical, and behavioral data, the hypothesis that an abnormally reactive cortical cholinergic input system represents a necessary correlate of a sensitized mesolimbic dopaminergic system is discussed. Moreover, the abnormal cognitive mechanisms that contribute to the development of psychotic symptoms are attributed specifically to the aberrations in cortical cholinergic transmission and to its consequences on the top-down regulation of sensory and sensory-associational input functions. Experimental evidence from studies demonstrating repeated amphetamine-induced sensitization of cortical cholinergic transmission and the ability of antipsychotic drugs to normalize the activity of cortical cholinergic inputs, and from experiments indicating the attentional consequences of manipulations that increase the excitability of cortical cholinergic inputs, supports this hypothesis. Relevant human neuropathological and psychopharmacological data are discussed, and the implications of an abnormally regulated cortical cholinergic input system for pharmacological treatment strategies are addressed. Given the role of cortical cholinergic inputs in gating cortical information processing, even subtle changes in the regulation of this cortexwide input system that represent a necessary transsynaptic consequence of sensitized mesolimbic dopaminergic transmission profoundly contribute to the neuronal mediation of psychotic symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Excessive cortical cholinergic activity in experimental animals results in “hyperattentive impairments” (Sarter et al. 2005), where over activity of the cholinergic system reduces the signal detection threshold and leads to over processing of stimuli.”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Sarter et al. 2005
In the citing paper
“Persistent spiking may contribute to the generation of responses in the sustained attention task (Sarter et al, 2005; McGaughy and Sarter, 1998).”
From Modes and models of forebrain cholinergic neuromodulation of cognition (2011) · cites this paper as Sarter et al, 2005
Citations
Cites
Items 201–326 of 326
Gaykema, R. P., & Zaborszky, L. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961028)374:4<555::aid-cne6>3.0.co;2-0 · Cited by 106 · cited 3×
“…the amygdala (Fallon et al. 1978; Kelley et al. 1982; Wright et al. 1996), and the amygdala and the BF (e.g., Jolkkonen et al. 2002), and the direct projections of the ventral tegmentum to the BF (Gaykema and Zaborszky 1996; Momiyama and Sim 1996; Zaborszky and Cullinan 1996; Smiley et al. 1999).”
BackgroundSchizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence
LeDuc, P. A., & Mittleman, G. (1995) · Psychopharmacology · doi:10.1007/bf02246489 · Cited by 105 · cited 1×
“Alternatively, the risk for psychostimulant addiction represents a corollary of schizophrenic neuropathology (e.g., Segal et al. 1981; Robinson and Becker 1986; LeDuc and Mittleman 1995; Lieberman et al. 1997; Yui et al. 1999a; Castner et al. 2000; Laruelle 2000).”
BackgroundSarter, M. F., & Bruno, J. P. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90001-9 · Cited by 103 · cited 3×
“…the regulation of cortical ACh efflux by BF GABAergic inputs by demonstrating that the 120 systemic or intra-BF administration of positive and negative GABA modulators (BZR agonists and inverse agonists ) bidirectionally regulates cortical ACh efflux (Sarter and Bruno 1994; Bruno and Miller 1995).”
InfluentialSelf-citationNelson, E. B., Sax, K. W., & Strakowski, S. M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.137 · Cited by 102 · cited 2×
“The hypothesis that such attentional impairments are intrinsically related to the neurobiological bases and the development of positive symptoms of this disorder, while entailing complexities and not being universally accepted (Green and Nuechterlein 1999), has been extensively substantiated (e.g., Freedman et al. 199…”
BackgroundKimura, F., & Baughman, R. W. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.2.709 · Cited by 102 · cited 2×
“…activity in the cortex produces a complex combination of inhibitory and excitatory effects (e.g., Hasselmo and Bower 1992; McCormick et al. 1993; Kimura and Baughman 1997; Tang et al. 1997), which, in more functional terms, enhances the effects of glutamatergic inputs via NMDA receptors…”
BackgroundTam, S., & Roth, R. H. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90708-7 · Cited by 101 · cited 2×
“Furthermore, FG 7142 increases mesolimbic DA efflux (Tam and Roth 1985; Brose et al. 1987; Bradberry et al. 1991; McCullough and Salamone 1992; Bassareo et al. 1996) and, with remarkable efficacy, basal cortical ACh efflux (up to 400% over baseline reported in Moore et al.”
BackgroundReduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia
Mancama, D., Arranz, M., Landau, S., & Kerwin, R. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20020 · Cited by 101 · cited 1×
“Neuropathological data suggesting an abnormal regulation of the cortical cholinergic input system in schizophrenia remain rare and inconclusive, mostly because dynamic alterations in the activity of cholinergic neurons cannot be readily revealed by neuropathological assessments of the activity of non-rate-limiting enz…”
BackgroundBassareo, V., Tanda, G., Petromilli, P., Giua, C., & Chiara, G. D. (1996) · Psychopharmacology · doi:10.1007/bf02247433 · Cited by 100
Tsukada, H., Nishiyama, S., Kakiuchi, T., Ohba, H., Sato, K., & Harada, N. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01834-x · Cited by 100 · cited 2×
“Although the interpretation of the mechanisms mediating the AMPH-induced displacement of D2 ligands is not without controversy (Tsukada et al. 1999), the use of AMPH in these studies corresponds with the psychotogenic effects of repeated exposure to AMPH and other psychostimulants in humans and in animal models of sch…”
BackgroundGluck, M. R., Thomas, R. G., Davis, K. L., & Haroutunian, V. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1165 · Cited by 99 · cited 2×
“…prefrontal neurotransmission , possibly in interaction with structural abnormalities of the PFC in schizophrenia patients (e.g., Lewis et al. 1999; Gluck et al. 2002), contribute via corticofugal projections to the abnormal regulation of striatal, including NAC, DA transmission (e.g., Deutch…”
BackgroundMulholland, G. K., Wieland, D. M., Kilbourn, M. R., Frey, K. A., Sherman, P. S., Carey, J. E., & Kuhl, D. E. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199811)30:3<263::aid-syn4>3.0.co;2-9 · Cited by 97
Vertes, R. P., & Crane, A. M. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961028)374:4<607::aid-cne9>3.0.co;2-5 · Cited by 96
Yui, K., Goto, K., Ikemoto, S., Ishiguro, T., Angrist, B., Duncan, G. E., Sheitman, B., Lieberman, J. A., Bracha, S., & Ali, S. F. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000575 · Cited by 95 · cited 3×
“Alternatively, the risk for psychostimulant addiction represents a corollary of schizophrenic neuropathology (e.g., Segal et al. 1981; Robinson and Becker 1986; LeDuc and Mittleman 1995; Lieberman et al. 1997; Yui et al. 1999a; Castner et al. 2000; Laruelle 2000).”
BackgroundInduction of behavioral associative memory by stimulation of the nucleus basalis
McLin, D. E., Miasnikov, A. A., & Weinberger, N. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062057099 · Cited by 93 · cited 2×
“This hypothesis corresponds with the demonstration that BF electrical stimulation, when paired with a neutral stimulus , empowers this stimulus to exert behavioral control akin to a conditioned stimulus (McLin et al. 2002).”
Zaborszky, L., & Cullinan, W. E. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961028)374:4<535::aid-cne5>3.0.co;2-2 · Cited by 93 · cited 4×
“…the amygdala (Fallon et al. 1978; Kelley et al. 1982; Wright et al. 1996), and the amygdala and the BF (e.g., Jolkkonen et al. 2002), and the direct projections of the ventral tegmentum to the BF (Gaykema and Zaborszky 1996; Momiyama and Sim 1996; Zaborszky and Cullinan 1996; Smiley et al. 1999).”
BackgroundInfluentialAcetylcholine-induced inhibition in the cat visual cortex is mediated by a GABAergic mechanism
Müller, C. M., & Singer, W. (1989) · Brain Research · doi:10.1016/0006-8993(89)90837-8 · Cited by 92 · cited 1×
“In the visual cortex, application of ACh generally enhances stimulus-driven neuronal activity; importantly, this enhancement is accompanied by a decrease of directional selectivity of visual cortical units (Sato et al. 1987; Muller and Singer 1989).”
BackgroundJentsch, J. D., Taylor, J. R., Elsworth, J. D., Redmond, D. E., & Roth, R. H. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00481-3 · Cited by 91 · cited 2×
“The reduced prefrontal dopaminergic transmission produced by repeated NMDA antagonist administration (Jentsch et al. 1999), but not repeated psychostimulant exposure (Hamamura and Fibiger 1993; Stephans and Yamamoto 1995; Pierce and Kalivas 1997), and additional cortical pathology that is possibly…”
BackgroundBradberry, C. W., Lory, J. D., & Roth, R. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb01987.x · Cited by 88 · cited 2×
“Furthermore, FG 7142 increases mesolimbic DA efflux (Tam and Roth 1985; Brose et al. 1987; Bradberry et al. 1991; McCullough and Salamone 1992; Bassareo et al. 1996) and, with remarkable efficacy, basal cortical ACh efflux (up to 400% over baseline reported in Moore et al.”
BackgroundNapier, T. C., Mitrovic, I., Churchill, L., Klitenick, M. A., Lu, X.-Y., & Kalivas, P. W. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00218-8 · Cited by 86 · cited 1×
“There is evidence for other types of NAC projections to the BF (e.g., Napier et al. 1995), but this anatomical organization remains unsettled.”
BackgroundMogenson, G. J., Ciriello, J., Garland, J. C., & Wu, M. (1987) · Brain Research · doi:10.1016/0006-8993(87)91373-4 · Cited by 86 · cited 2×
“…to the MD is also shown because, via this projection (and also possibly via noncholinergic BF projections to the MD; e.g., Young et al. 1984; Mogenson et al. 1987; Hreib et al. 1988), the MD's projections to the PFC (e.g., Sarter and Markowitsch 1984) may also be abnormally regulated and…”
BackgroundFeeding-evoked dopamine release in the nucleus accumbens: regulation by glutamatergic mechanisms
Taber, M. T., & Fibiger, H. C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00450-2 · Cited by 86 · cited 1×
“The regulation of NAC output neurons by NAC dopaminergic inputs is complex and depends strictly on interactions with NAC glutamatergic inputs from telencephalic regions (Burns et al. 1994; Taber and Fibiger 1997).”
BackgroundBurk, J. A., & Sarter, M. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00233-0 · Cited by 86 · cited 2×
“Analyses of response times indicated that increases in the false alarm rate are due in part to a disruption of the animals’ ability to switch from the processing of the dominant response rule for signal trials to the rule that governs rewarded lever selection for nonsignal trials (Burk and Sarter 2001).”
BackgroundSelf-citationThe neuropsychology of schizophrenia: relations with clinical and neurobiological dimensions
Elliott, R., & Sahakian, B. J. (1995) · Psychological Medicine · doi:10.1017/s0033291700033493 · Cited by 85 · cited 2×
“…limited capability in determining the specific characteristics of the attentional disorder of patients (Elvevag et al. 2000) and in revealing the role of attentional impairments in the development of schizophrenic symptoms (Elliott and Sahakian 1995; Green et al. 2000; Phillips and David 2000).”
BackgroundMirsky, A. F., Yardley, S. L., Jones, B. P., Walsh, D., & Kendler, K. S. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)00041-o · Cited by 84 · cited 2×
“However, a comprehensive cognitive theory describing the development of psychotic symptoms as a result of the dynamic, escalating cognitive consequences of years of initially more subtle impairments in the ability to select stimuli and associations for further processing, to filter irrelevant inputs, and to organize p…”
BackgroundBrain region effects of clozapine on amino acid and monoamine transmission.
Yamamoto, B. K., Pehek, E. A., & Meltzer, H. Y. (1994) · PubMed · Cited by 83
In Vivo Olanzapine Occupancy of Muscarinic Acetylcholine Receptors in Patients with Schizophrenia
Raedler, T. J. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00162-1 · Cited by 82 · cited 2×
“1996), reflected by the finding that the discriminative stimulus properties of this drug potently generalize to those of atropine and scopolamine (Nielsen 1988), suggests that the increase in ACh release produced by acute administration of atypical antipsychotic drugs is due, at least in part, to presynaptic muscarini…”
BackgroundProjections from the amygdaloid complex to the magnocellular cholinergic basal forebrain in rat
Jolkkonen, E., Miettinen, R. A., Pikkarainen, M., & Pitkänen, A. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00578-4 · Cited by 81 · cited 2×
“…antagonist exposure also disrupts the regulation of the BF via prefrontal and amygdaloid afferents (Zaborszky et al. 1997; see the discussion in Jolkkonen et al. 2002; Rosenkranz and Grace 2002; Sarter and Bruno 2002) and thereby contributes to the inability of repeated exposure to NMDA…”
BackgroundWu, M., Brudzynski, S. M., & Mogenson, G. J. (1993) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y93-061 · Cited by 81 · cited 2×
“Dopaminergic inputs to the NAC, originating in the ventral tegmental area, converge with telencephalic (glutamatergic) projections on medium spiny NAC efferents (Sesack and Pickel 1990; Wu et al. 1993; Taber and Fibiger 1995; Finch 1996; Whitelaw et al. 1996; Blaha et al. 1997; Floresco et al. 1998; Mulder et al. 1998…”
BackgroundDopaminergic Reduction of Excitability in Nucleus Accumbens Neurons Recorded in Vitro
O’Donnell, P., & Grace, A. A. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00177-f · Cited by 80 · cited 1×
“Moreover, prefrontal, hippocampal, and amygdaloid projections to the NAC are differently modulated by DA D1 and D2 receptors (O’Donnell and Grace 1996; Charara and Grace 2003).”
BackgroundMonoaminergic–cholinergic interactions in the primate basal forebrain
Smiley, J. F., Subramanian, M., & Mesulam, M.-M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00116-5 · Cited by 79 · cited 2×
“…the amygdala (Fallon et al. 1978; Kelley et al. 1982; Wright et al. 1996), and the amygdala and the BF (e.g., Jolkkonen et al. 2002), and the direct projections of the ventral tegmentum to the BF (Gaykema and Zaborszky 1996; Momiyama and Sim 1996; Zaborszky and Cullinan 1996; Smiley et al. 1999).”
BackgroundGray, J. A. (1995) · Neuropsychologia · doi:10.1016/0028-3932(95)00054-7 · Cited by 78 · cited 2×
“Thus, the available evidence points to the NAC, particularly its shell region, as the critical component of abnormally regulated neuronal circuits mediating the expression of positive symptoms (O’Donnell and Grace 1998), or even the aberrations of consciousness, in schizophrenia (Gray 1995).”
BackgroundAmphetamine lowers extracellular GABA concentration in the ventral pallidum
Bourdelais, A. J., & Kalivas, P. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)90907-s · Cited by 74 · cited 2×
“…projection to the BF. Kalivas and colleagues demonstrated that systemic administration of AMPH decreases GABA efflux in the ventral pallidum (Bourdelais and Kalivas 1990) and that the effects of systemic apomorphine (a DA agonist) on BF GABA efflux are potentiated by a prior depletion of…”
BackgroundCapacity limitations in short-term memory in schizophrenia: tests of competing hypotheses
GOLDBERG, T. E., PATTERSON, K. J., TAQQU, Y., & WILDER, K. (1998) · Psychological Medicine · doi:10.1017/s0033291797006429 · Cited by 74 · cited 2×
“These impairments likely are associated with, or even due to, the exhaustion of attentional resources by the processing of task-irrelevant information (e.g., Nuechterlein and Dawson 1984; Grillon et al. 1990; Granholm et al. 1991; Spring 1992; Goldberg et al. 1998; Seidman et al. 1998; Alain et al. 2002; Potts et al.…”
BackgroundShannon, H. E., Hart, J. C., Bymaster, F. P., Calligaro, D. O., DeLapp, N. W., Mitch, C. H., Ward, J. S., Fink‐Jensen, A., Sauerberg, P., Jeppesen, L., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34979-1 · Cited by 73 · cited 1×
“Based on these findings and considerations, novel muscarinic agonists or positive modulators of muscarinic transmission are being developed for the treatment of schizophrenia (Shannon et al. 1999, 2000; Felder et al. 2001; Stanhope et al. 2001).”
BackgroundMoore, H., Stuckman, S., Sarter, M., & Bruno, J. P. (1995) · Synapse · doi:10.1002/syn.890210407 · Cited by 73 · cited 2×
“…of a BZR inverse agonist augment the increases in cortical ACh efflux that result from the presentation of an activating appetitive stimulus (Moore et al. 1995a) and, in rats tested in an operant task designed to assess sustained attention performance , impair performance by increasing the…”
BackgroundSelf-citationEffects of cholinergic modulation on responses of neocortical neurons to fluctuating input
Tang, A. (1997) · Cerebral Cortex · doi:10.1093/cercor/7.6.502 · Cited by 72 · cited 2×
“…produces a complex combination of inhibitory and excitatory effects (e.g., Hasselmo and Bower 1992; McCormick et al. 1993; Kimura and Baughman 1997; Tang et al. 1997), which, in more functional terms, enhances the effects of glutamatergic inputs via NMDA receptors (Aramakis et al. 1997) and…”
BackgroundCritical Review of GABA-ergic Drugs in the Treatment of Schizophrenia
Wassef, A. A., Dott, S. G., Harris, A., Brown, A., O'Boyle, M., Meyer, W. J., & Rose, R. M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199906000-00004 · Cited by 68 · cited 2×
“1989), and, when coadministered with typical antipsychotic drugs, in enhancing the therapeutic efficacy and reducing the daily doses of the antipsychotic drug required (Bodkin 1990; Wolkowitz and Pickar 1991; Wassef et al. 1999).”
BackgroundEffect of smoking on neuroleptics in schizophrenia
Salokangas, R. K. R., Saarijãrvi, S., Taiminen, T. J., Lehto, H., Niemi, H., Ahola, V., & Syvälahti, E. K. G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00083-7 · Cited by 68 · cited 1×
“1990), as do the functions of smoking and the status of nicotine receptors in schizophrenia (Salokangas et al. 1997; Adler et al. 1998; Dalack et al. 1998).”
BackgroundCortical cholinergic markers in schizophrenia
Haroutunian, V. H., Davidson, M., Kanof, P. D., Perl, D. P., Powchik, P., LOSONCZY, M. F., McCrystal, J., Purohit, D. P., Bierer, L. M., & Davis, K. L. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90071-x · Cited by 67
Brown, V. J., & Bowman, E. M. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01046.x · Cited by 67 · cited 1×
“This interaction is generally considered to be critical for the selection of stimuli to act as conditioned reinforcers and to guide instrumental behavior (Cador et al. 1989, 1991; Everitt et al. 1989; Salamone 1994; Brown and Bowman 1995).”
BackgroundWhen does amphetamine-induced psychosis become schizophrenia? [clinical conference]
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.6.812 · Cited by 67
Stimulant-induced psychosis: an evaluation of animal methods.
Segal, D. S., Geyer, M. A., & Schuckit, M. A. (1981) · PubMed · Cited by 67
Strakowski, S. M., Sax, K. W., Setters, M. J., Stanton, S. P., & Keck, P. E. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00052-8 · Cited by 64 · cited 3×
“…system in schizophrenia patients can be demonstrated even in never-medicated patients; such demonstration requires the presence of psychotic symptoms (Laruelle et al. 1996, 1999; Strakowski et al. 1997; Abi-Dargham et al. 1998; Laruelle and Abi-Dargham 1999; Laruelle 2000; Seeman and Kapur 2000).”
BackgroundJentsch, J. D., Dazzi, L., Chhatwal, J. P., Verrico, C. D., & Roth, R. H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00879-9 · Cited by 64 · cited 3×
“These data indicate interesting and unsettled dissociations between the effects 121 of repeated exposure of different psychotogenic treatments , particularly when considering that repeated PCP also sensitizes the ventral striatal dopaminergic system and increases AMPH-induced behaviors (Jentsch et al. 1998b; see also…”
BackgroundJones, S. H., Hemsley, D., Ball, S., & Serra, A. M. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)02312-7 · Cited by 64 · cited 2×
“…1999), has been extensively substantiated (e.g., Freedman et al. 1991; Serper et al. 1994; Servan- Schreiber et al. 1996; Berman et al. 1997; Jones et al. 1997; Velligan et al. 1997; Cohen et al. 1998; Nelson et al. 1998; Brebion et al. 1999; Cadenhead and Braff 2000; Dawson et al. 2000;…”
BackgroundBasal forebrain glutamatergic modulation of cortical acetylcholine release
Fadel, J., Sarter, M., & Bruno, J. P. (2001) · Synapse · doi:10.1002/1098-2396(20010301)39:3<201::aid-syn1001>3.0.co;2-3 · Cited by 64 · cited 1×
“Likewise, infusions of NMDA into the BF augment stimulated cortical ACh efflux (Fadel et al. 2001) and produce the same pattern of attentional impairment (Turchi and Sarter 2001b).”
BackgroundSelf-citationElvevåg, B., Weinberger, D. R., Suter, J. C., & Goldberg, T. E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.772 · Cited by 63 · cited 2×
“, Continuous Performance Task [CPT]) have limited capability in determining the specific characteristics of the attentional disorder of patients (Elvevag et al. 2000) and in revealing the role of attentional impairments in the development of schizophrenic symptoms (Elliott and Sahakian 1995; Green et al.”
BackgroundWebster, H. H., Rasmusson, D. D., Dykes, R. W., Schliebs, R., Schober, W., Bru¨ckner, G., & Biesold, D. (1991) · Brain Research · doi:10.1016/0006-8993(91)91300-p · Cited by 63 · cited 1×
“In the somatosensory cortex, stimulation of the cholinergic BF enhances the responses of neurons to stimulation of the skin (Rasmusson and Dykes 1988; Webster et al. 1991).”
BackgroundTurchi, J. N., & Sarter, M. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00089-6 · Cited by 61 · cited 2×
“Likewise, infusions of NMDA into the BF augment stimulated cortical ACh efflux (Fadel et al. 2001) and produce the same pattern of attentional impairment (Turchi and Sarter 2001b).”
BackgroundSelf-citationFunctional neuroanatomy of sustained attention in schizophrenia: Contribution of parietal cortices
Ojeda, N., Ortuño, F., Arbizu, J., López, P., Martí‐Climent, J. M., Peñuelas, I., & Cervera‐Enguix, S. (2002) · Human Brain Mapping · doi:10.1002/hbm.10055 · Cited by 58 · cited 1×
“Furthermore, experiments designed to assess cortical functioning in patients while their attentional capacities are taxed will assist in defining the consequences of abnormally regulated attentional systems (Ojeda et al. 2002).”
BackgroundEnsemble coding in the nucleus accumbens
O’Donnell, P. (1999) · Psychobiology · doi:10.3758/bf03332113 · Cited by 58 · cited 3×
“O'Donnell (1999) stressed that the effects of DA on NAC output neurons cannot be simplified as excitatory or inhibitory but depend on whether these neurons Fig.”
BackgroundMele, A., Thomas, D. N., & Pert, A. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00277-7 · Cited by 58 · cited 4×
“…mechanisms mediating these effects requires more experimentation and may differ from the mediation of the effects of systemic or intra-NAC psychostimulants (Mele et al. 1998), these data support the notion that alteration of NAC output profoundly changes the regulation of cortical ACh efflux.”
BackgroundInfluentialPatel, S., & Slater, P. (1988) · Behavioral Neuroscience · doi:10.1037/0735-7044.102.4.596 · Cited by 57 · cited 1×
“Patel and Slater found that the ability of NAC infusions of DA agonists to stimulate locomotion is attenuated by infusions of muscimol into the ventral pallidal area (Patel and Slater 1988; see also Mogenson et al. 1983; Sarter et al. 1990; Mele et al. 1998).”
BackgroundBasal forebrain efferents to the medial dorsal thalamic nucleus in the rhesus monkey
Hreib, K. K., Rosene, D. L., & Moss, M. B. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902770304 · Cited by 56 · cited 2×
“…shown because, via this projection (and also possibly via noncholinergic BF projections to the MD; e.g., Young et al. 1984; Mogenson et al. 1987; Hreib et al. 1988), the MD's projections to the PFC (e.g., Sarter and Markowitsch 1984) may also be abnormally regulated and thus further impair…”
BackgroundEmerging uses for high-potency benzodiazepines in psychotic disorders.
Bodkin, J. A. (1990) · PubMed · Cited by 56
Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients?
Light, G. A., & Braff, D. L. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00280-2 · Cited by 55 · cited 2×
“However, other, more experimental studies revealed the ‘‘hyperattentional’’ nature of their deficits, in both medicated and medication-withdrawn subjects (Mar et al. 1996; Salo et al. 1996; Light and Braff 2000).”
ResultParada, M. A., Hernandez, L., de Parada, M. P., Rada, P. V., & Murzi, E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36626-1 · Cited by 55 · cited 2×
“Several experiments documented that the acute administration of atypical antipsychotic drugs (clozapine, olanzapine) potently increases basal hippocampal and cortical ACh efflux (Parada et al. 1997; Ichikawa et al. 2002; Shirazi-Southall et al. 2002).”
BackgroundOpposite links of positive and negative symptomatology with memory errors in schizophrenia
Brébion, G., Amador, X., Smith, M. J., Malaspina, D., Sharif, Z., & Gorman, J. M. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00076-1 · Cited by 55 · cited 2×
“The hypothesis that such attentional impairments are intrinsically related to the neurobiological bases and the development of positive symptoms of this disorder, while entailing complexities and not being universally accepted (Green and Nuechterlein 1999), has been extensively substantiated (e.g., Freedman et al. 199…”
BackgroundCholinergic mediation of the discriminative stimulus properties of clozapine
Nielsen, E. B. (1988) · Psychopharmacology · doi:10.1007/bf00735891 · Cited by 55 · cited 2×
“…1996), reflected by the finding that the discriminative stimulus properties of this drug potently generalize to those of atropine and scopolamine (Nielsen 1988), suggests that the increase in ACh release produced by acute administration of atypical antipsychotic drugs is due, at least in part,…”
BackgroundMussgay, L., & Hertwig, R. (1990) · Schizophrenia Research · doi:10.1016/0920-9964(90)90014-x · Cited by 55 · cited 1×
“…said to suffer from ''hypervigilance ,'' studies using standardized CPTs for the assessment of attentional abilities rarely demonstrated the characteristics of the specific attentional impairments of schizophrenia patients (e.g., Nuechterlein and Dawson 1984; Mussgay and Hertwig 1990; Spring 1992).”
BackgroundCastner, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00080-9 · Cited by 54 · cited 1×
“Alternatively, the risk for psychostimulant addiction represents a corollary of schizophrenic neuropathology (e.g., Segal et al. 1981; Robinson and Becker 1986; LeDuc and Mittleman 1995; Lieberman et al. 1997; Yui et al. 1999a; Castner et al. 2000; Laruelle 2000).”
BackgroundModulation of cognitive processes by transsynaptic activation of the basal forebrain
Givens, B. S., & Sarter, M. F. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(96)00146-5 · Cited by 54 · cited 1×
“…neurons, via multiple afferent routes, including ventral tegmental (e.g., Momiyama and Sim 1996) and amygdaloid connections (see above; see also Givens and Sarter 1997), converge with decreases in BF afferent GABAergic activity to yield the observed increases in cortical ACh release (figure 1).”
BackgroundSelf-citationActivation of muscarinic receptors modulates NMDA receptor-mediated responses in auditory cortex
Aramakis, V. B., Bandrowski, A. E., & Ashe, J. H. (1997) · Experimental Brain Research · doi:10.1007/pl00005601 · Cited by 53 · cited 2×
“1997), which, in more functional terms, enhances the effects of glutamatergic inputs via NMDA receptors (Aramakis et al. 1997) and desynchronizes cortical efferent neurons (Givens et al.”
BackgroundMomiyama, T., & Sim, J. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-23-07505.1996 · Cited by 52 · cited 5×
“…1988) are also likely to contribute directly and indirectly to the abnormal regulation of the cortical cholinergic inputs, but data specifying these dopamine-cholinergic interactions in the BF, or the dopaminergic regulation of MD efferents, are rare (Momiyama and Sim 1996; Lavin and Grace 1998).”
BackgroundInfluentialDisorders of Attention and Perception in Early Schizophrenia
Kiev, A. (1962) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1962.16.2.350 · Cited by 51
Schizophrenia: yesterday's concept
Brockington, I. (1992) · European Psychiatry · doi:10.1017/s0924933800003436 · Cited by 51 · cited 1×
“In fact, the clinical literature occasionally classified attentional impairments as a negative symptom, or suggested inconsistent relationships between attentional impairments and positive symptoms (but see Addington et al. 1991; Brockington 1992).”
BackgroundMesoprefrontal Dopamine Neurons and Schizophrenia: Role of Developmental Abnormalities
Finlay, J. M. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006885 · Cited by 51 · cited 2×
“2002), contribute via corticofugal projections to the abnormal regulation of striatal, including NAC, DA transmission (e.g., Deutch 1993; Bertolino et al. 1999; Carr et al. 1999; Moore et al. 1999b; Soares and Innis 1999; Finlay 2001).”
BackgroundTrihexyphenidyl abuse: therapeutic implications for negative symptoms of schizophrenia?
Fisch, R. Z. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02757.x · Cited by 51 · cited 1×
“, trihexyphenidyl, benztropine) by schizophrenia patients, who report a wide spectrum of subjective and functional benefits from taking these drugs (Fisch 1987; Wells et al. 1989), also provides indirect support for the idea that attenuation of an overly active or reactive cholinergic system mediates beneficial effect…”
BackgroundPsychotogenic properties of benzodiazepine receptor inverse agonists
Sarter, M. F., Bruno, J. P., & Berntson, G. G. (2001) · Psychopharmacology · doi:10.1007/s002130100756 · Cited by 50 · cited 3×
“…to affect the regulation of cortical ACh efflux , the effects of certain BZR inverse agonists, particularly the partial inverse agonist b-carboline FG 7142, traditionally classified as an anxiogenic compound, have been reconceptualized as indicating psychotogenic properties (Sarter et al. 2001a).”
BackgroundSelf-citationMach, R. H., Voytko, M. L., Ehrenkaufer, R. L., Nader, M. A., Tobin, J. R., Efange, S. M. N., Parsons, S. M., Gage, H. D., Smith, C. R., & Morton, T. E. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199704)25:4<368::aid-syn8>3.0.co;2-8 · Cited by 50
Disruption of Neural Systems of Visual Attention in Schizophrenia
Potts, G. F., O'Donnell, B. F., Hirayasu, Y., & McCarley, R. W. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.418 · Cited by 49 · cited 2×
“These impairments likely are associated with, or even due to, the exhaustion of attentional resources by the processing of task-irrelevant information (e.g., Nuechterlein and Dawson 1984; Grillon et al. 1990; Granholm et al. 1991; Spring 1992; Goldberg et al. 1998; Seidman et al. 1998; Alain et al. 2002; Potts et al.…”
BackgroundGranholm, E. L., Asarnow, R. F., & Marder, S. R. (1991) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.100.1.22 · Cited by 49 · cited 2×
“These impairments likely are associated with, or even due to, the exhaustion of attentional resources by the processing of task-irrelevant information (e.g., Nuechterlein and Dawson 1984; Grillon et al. 1990; Granholm et al. 1991; Spring 1992; Goldberg et al. 1998; Seidman et al. 1998; Alain et al. 2002; Potts et al.…”
BackgroundEffects of cholinergic enhancement on conditioning‐related responses in human auditory cortex
Thiel, C. M., Bentley, P., & Dolan, R. J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02272.x · Cited by 48 · cited 2×
“A recent study in human volunteers (Thiel et al. 2002) demonstrated that administration of the acetylcholinesterase inhibitor physostigmine, which results in high levels of ACh and thus abnormal levels of cholinergic receptor stimulation, yielded increases in the auditory cortical metabolic…”
BackgroundBall, S., Busatto, G. F., David, A. S., Jones, S. H., Hemsley, D. R., Pilowsky, L. S., Costa, D. C., Ell, P. J., & Kerwin, R. W. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00300-4 · Cited by 48 · cited 1×
“…the status of cortical muscarinic and nicotinic receptors as well as of other cortical receptor systems modulated by cholinergic 127 inputs (e.g., Ball et al. 1998) remains unclear but is critical for the understanding of the long-term consequences of increased reactivity of cortical cholinergic…”
BackgroundRepeated pretreatment with amphetamine sensitizes increases in cortical acetylcholine release
Nelson, C. L., Sarter, M. F., & Bruno, J. P. (2000) · Psychopharmacology · doi:10.1007/s002130000494 · Cited by 48 · cited 3×
“However, administration of AMPH 19 days after the initial regimen resulted in significant augmentation of, or sensitization of, the increase in cortical ACh efflux (for details and control experiments, see Nelson et al. 2000).”
BackgroundMethodInfluentialSelf-citationDeller, T., & Sarter, M. F. (1998) · Psychopharmacology · doi:10.1007/s002130050637 · Cited by 47 · cited 1×
“…used by Nelson et al. (2000) to demonstrate AMPH-induced augmentation of increases in cortical ACh efflux (see above) was used, repeated AMPH produced a ''sensitized'' impairment in the performance of this task that again was characterized by an increased false alarm rate (Deller and Sarter 1998).”
MethodSelf-citationDopamine Modulates the Responsivity of Mediodorsal Thalamic Cells Recorded In Vitro
Lavin, A., & Grace, A. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10566.1998 · Cited by 46 · cited 2×
“…1988) are also likely to contribute directly and indirectly to the abnormal regulation of the cortical cholinergic inputs, but data specifying these dopamine-cholinergic interactions in the BF, or the dopaminergic regulation of MD efferents, are rare (Momiyama and Sim 1996; Lavin and Grace 1998).”
BackgroundSeidman, L. J., Manen, K.-J. V., Turner, W. M., Gamser, D. M., Faraone, S. V., Goldstein, J. M., & Tsuang, M. T. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00097-8 · Cited by 46 · cited 1×
“…associated with, or even due to, the exhaustion of attentional resources by the processing of task-irrelevant information (e.g., Nuechterlein and Dawson 1984; Grillon et al. 1990; Granholm et al. 1991; Spring 1992; Goldberg et al. 1998; Seidman et al. 1998; Alain et al. 2002; Potts et al. 2002).”
BackgroundCohen, R. M. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00201-7 · Cited by 46 · cited 2×
“The hypothesis that such attentional impairments are intrinsically related to the neurobiological bases and the development of positive symptoms of this disorder, while entailing complexities and not being universally accepted (Green and Nuechterlein 1999), has been extensively substantiated (e.g., Freedman et al. 199…”
BackgroundFurther evidence for a deficit in switching attention in schizophrenia.
Smith, G. L., Large, M. M. B., Kavanagh, D. J., Karayanidis, F., Barrett, N. A., Michie, P. T., & O’Sullivan, B. T. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.3.390 · Cited by 45 · cited 2×
“Furthermore, ample evidence supports the notion that stimulus detection and discrimination functions are impaired and that attentional capacities, including the capacity for switching attention (Smith et al. 1998) and processing errors (Alain et al. 2002), are reduced in schizophrenia patients.”
BackgroundSalo, R. E., Robertson, L. C., & NORDAHL, T. E. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02804-1 · Cited by 45 · cited 2×
“However, other, more experimental studies revealed the ‘‘hyperattentional’’ nature of their deficits, in both medicated and medication-withdrawn subjects (Mar et al. 1996; Salo et al. 1996; Light and Braff 2000).”
ResultBehavioural Vigilance in Schizophrenia: Evidence for Hyperattentional Processing
Mar, C. M., Smith, D. A., & Sarter, M. F. (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.169.6.781 · Cited by 44
Self-citationBenzodiazepine receptor inverse agonists
(1996) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1996.tb00195.x · Cited by 44
Darracq, L., Drouin, C., Blanc, G., Glowinski, J., & Tassin, J. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00578-9 · Cited by 44 · cited 2×
“Finally, increases in activity of DA NAC inputs are observed in association with converging glutamatergic activity (Youngren et al. 1993; Darracq et al. 2001; Floresco et al. 2001a, 2001b, 2001c; Howland et al. 2002 ), suggesting that the modulatory function of DA is partly regulated by…”
BackgroundCholinergic involvement in mental disorders
Davis, K. L., Berger, P. A., Hollister, L. E., & Barchas, J. D. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90472-1 · Cited by 44
Compton, D. M., & Johnson, K. M. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23733-8 · Cited by 39 · cited 1×
“Moreover, chronically administered clozapine fundamentally changes NAC throughput (e.g., Compton and Johnson 1989), thus altering the telencephalic influence on the 126 regulation of cortical cholinergic inputs.”
BackgroundDopamine depletion attenuates amphetamine-induced increases of cortical acetylcholine release
Day, J. C., Tham, C., & Fibiger, H. C. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90724-2 · Cited by 36 · cited 2×
“1999a) corresponds with the assumption that the effects of systemically administered DA antagonists on cortical ACh efflux primarily involve NAC mechanisms (see also Bianchi et al. 1979; Day et al. 1994).”
BackgroundShould schizophrenia be treated as a neurocognitive disorder?
Green, M. F. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)80104-7 · Cited by 36
Delini‐Stula, A., & Berdah-Tordjman, D. (1996) · Journal of Psychiatric Research · doi:10.1016/0022-3956(96)00003-9 · Cited by 35 · cited 1×
“While chronic treatment with such drugs appears limited by rapid BZR downregulation, several studies demonstrated the usefulness and potency of BZR agonists in exhibiting antipsychotic effects (Llorca et al. 1991; Delini-Stula et al. 1992; Jaspert and Ebert 1994; Delini-Stula and Berdah-Tordjman 1995; Delini-Stula and…”
BackgroundTandon, R., Greden, J. F., & Haskett, R. F. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90004-3 · Cited by 35
NMDA-Sensitive Glutamate Antagonism A Human Model for Psychosis
Lahti, A. C. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00132-3 · Cited by 34 · cited 2×
“Administration of the psychotogenic noncompetitive NMDA receptor antagonist ketamine (Krystal et al. 1994; Lahti et al. 1999; Newcomer et al. 1999) produces large (>250%) increases in cortical ACh efflux (Nelson et al.”
BackgroundKitamura, M., Ikeda, H., Koshikawa, N., & Cools, A. R. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00053-7 · Cited by 33 · cited 1×
“These findings support the hypothesis that the functional consequences of NAC DA receptor stimulation are mediated in part by a decrease in GABAergic output to the BF (see also Kitamura et al. 2001; figure 1).”
Attentional predictors of clinical change during neuroleptic treatment in schizophrenia
Serper, M. R., Davidson, M., & Harvey, P. D. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90061-2 · Cited by 32 · cited 2×
“The hypothesis that such attentional impairments are intrinsically related to the neurobiological bases and the development of positive symptoms of this disorder, while entailing complexities and not being universally accepted (Green and Nuechterlein 1999), has been extensively substantiated (e.g., Freedman et al. 199…”
BackgroundKelley, A. E., Domesick, V. B., & Nauta, W. J. H. (1982) · Neuroanatomy · doi:10.1007/978-1-4684-7920-1_24 · Cited by 31
Synaptic Organization of Basal Forebrain Cholinergic Projection Neurons
Záborszky, L. (1992) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9843-5_3 · Cited by 31 · cited 2×
“…pathway of the NAC shell reaches the ventral pallidum (Mogenson et al. 1983; Zahm and Brog 1992; Zahm and Heimer 1993; Usuda et al. 1998; Zahm et al. 1999) and appears to be largely GABAergic (GABA is c-aminobutyric acid; Walaas and Fonnum 1980; Zaborszky and Cullinan 1992; Zahm and Heimer 1993).”
BackgroundDopamine modulation of acetylcholine release from the guinea-pig brain
Bianchi, C., Tanganelli, S., & Beani, L. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90472-2 · Cited by 31 · cited 1×
“…were not attenuated by local cortical perfusion of DA receptor antagonists (Moore et al. 1999a) corresponds with the assumption that the effects of systemically administered DA antagonists on cortical ACh efflux primarily involve NAC mechanisms (see also Bianchi et al. 1979; Day et al. 1994).”
BackgroundBourdelais, A. J., & Kalivas, P. W. (1992) · Brain Research · doi:10.1016/0006-8993(92)90288-k · Cited by 31 · cited 2×
“Kalivas and colleagues demonstrated that systemic administration of AMPH decreases GABA efflux in the ventral pallidum (Bourdelais and Kalivas 1990) and that the effects of systemic apomorphine (a DA agonist) on BF GABA efflux are potentiated by a prior depletion of forebrain DA (Bourdelais and Kalivas 1992; see also…”
BackgroundChronic scopolamine treatment and brain cholinergic function
Marks, M. J., O’Connor, M. F., Artman, L. D., Burch, J. B., & Collins, A. C. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90198-9 · Cited by 31 · cited 1×
“After chronic administration of atypical antipsychotic drugs, alterations in muscarinic receptor regulation are likely to develop (e.g., Marks et al. 1984), and thus, the regulation of cortical ACh efflux may be fundamentally different when compared to the effects of the acute administration of…”
Brose, N., O'Neill, R., Boutelle, M., Anderson, S., & Fillenz, M. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-09-02917.1987 · Cited by 31 · cited 2×
“Furthermore, FG 7142 increases mesolimbic DA efflux (Tam and Roth 1985; Brose et al. 1987; Bradberry et al. 1991; McCullough and Salamone 1992; Bassareo et al. 1996) and, with remarkable efficacy, basal cortical ACh efflux (up to 400% over baseline reported in Moore et al.”
BackgroundMurphy, C. A., Iorio, L. D., & Feldon, J. (2001) · Psychopharmacology · doi:10.1007/s002130100759 · Cited by 30
Characterizing Anticholinergic Abuse in Community Mental Health
Wells, B. G., Marken, P. A., Rickman, L. A., Brown, C., Hamann, G. L., & GRIMMIG, J. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198912000-00009 · Cited by 30 · cited 1×
“, trihexyphenidyl, benztropine) by schizophrenia patients, who report a wide spectrum of subjective and functional benefits from taking these drugs (Fisch 1987; Wells et al. 1989), also provides indirect support for the idea that attenuation of an overly active or reactive cholinergic system mediates beneficial effect…”
BackgroundTsukada, H., Kakiuchi, T., Nishiyama, S., Ohba, H., Sato, K., Harada, N., & Takahashi, K. (2001) · Synapse · doi:10.1002/syn.1082 · Cited by 29 · cited 1×
“Emerging tracers for the imaging of cholinergic receptors and aspects of cholinergic transmission in the human brain (Mach et al. 1997; Mulholland et al. 1998; Nishiyama et al. 2000; Tsukada et al. 2001) are likely to pave the way for more direct and informative assessments of the status of cortical cholinergic transm…”
BackgroundImpérato, A., Puglisi‐Allegra, S., Scrocco, M. G., Casolini, P., Bacchi, S., & Angelucci, L. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90250-u · Cited by 27 · cited 1×
“…a sensitized mesolimbic DA system (e.g., Robinson and Becker 1986; Moghaddam 2002), and therefore possibly a sensitized cortical cholinergic input system (see also Imperato et al. 1992), the drug challenge models the effects of such stressors and is therefore an essential aspect of the model.”
BackgroundNeigh‐McCandless, G., Kravitz, B. A., Sarter, M., & Bruno, J. P. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02201.x · Cited by 26 · cited 1×
“A series of experiments demonstrated that blocking NMDA or AMPA/kainate ionotropic glutamate receptors in the shell region of the NAC resulted in marked and lasting increases in medial prefrontal basal ACh release (Neigh-McCandless et al. 2002).”
BackgroundSelf-citationTurchi, J., & Sarter, M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01610.x · Cited by 24 · cited 2×
“Likewise, infusions of NMDA into the BF augment stimulated cortical ACh efflux (Fadel et al. 2001) and produce the same pattern of attentional impairment (Turchi and Sarter 2001b).”
BackgroundSelf-citationYui, K., Goto, K., Ikemoto, S., Ishiguro, T., & Kamata, Y. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00008 · Cited by 23
Top-down modulation of early sensory cortex
Corbetta, M., Shulman, G. L., Buckner, R. L., Miezin, F. M., Raichle, M. E., & Petersen, S. E. (1996) · NeuroImage · doi:10.1016/s1053-8119(96)80178-9 · Cited by 23
Karczmar, A. G. (1981) · Advances in behavioral biology · doi:10.1007/978-1-4684-8643-8_85 · Cited by 21 · cited 1×
“Evidence in support of this statement remains necessarily anecdotal, but several cases of accidental chronic exposure to cholinesterase inhibitors (Gershon and Shaw 1961; Bowers et al. 1964; Karczmar 1981) indicated that persistent, abnormal increases in extracellular ACh levels are sufficient to produce or exacerbate…”
ResultPatel, S. S., & Slater, P. (1988) · Behavioral Neuroscience · doi:10.1037//0735-7044.102.4.596 · Cited by 19
Diazepam Treatment of Early Symptoms of Schizophrenic Relapse
Kirkpatrick, B. W., Buchanan, R. W., Waltrip, R. W., Jauch, D., & Carpenter, W. T. (1989) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198901000-00009 · Cited by 18 · cited 2×
“…the usefulness and potency of BZR agonists in exhibiting antipsychotic effects (Llorca et al. 1991; Delini-Stula et al. 1992; ) and relapse (Kirkpatrick et al. 1989), and, when coadministered with typical antipsychotic drugs, in enhancing the therapeutic efficacy and reducing the daily…”
BackgroundNishiyama, S., Sato, K., Harada, N., Kakiuchi, T., & Tsukada, H. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00167-0 · Cited by 17
PARTIAL BENZODIAZEPINE AGONISTS IN SCHIZOPHRENIA: EXPECTATIONS AND PRESENT CLINICAL FINDINGS
Delini‐Stula, A., Berdah-Tordjman, D., & Neumann, N.-U. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199201001-00211 · Cited by 17 · cited 2×
“…downregulation , several studies demonstrated the usefulness and potency of BZR agonists in exhibiting antipsychotic effects (Llorca et al. 1991; Delini-Stula et al. 1992; ) and relapse (Kirkpatrick et al. 1989), and, when coadministered with typical antipsychotic drugs, in enhancing the…”
BackgroundBenzodiazepines and GABA hypothesis of schizophrenia
Delini‐Stula, A., & Berdah-Tordjman, D. (1995) · Journal of Psychopharmacology · doi:10.1177/026988119500900109 · Cited by 16 · cited 1×
“While chronic treatment with such drugs appears limited by rapid BZR downregulation, several studies demonstrated the usefulness and potency of BZR agonists in exhibiting antipsychotic effects (Llorca et al. 1991; Delini-Stula et al. 1992; Jaspert and Ebert 1994; Delini-Stula and Berdah-Tordjman 1995; Delini-Stula and…”
BackgroundNinan, I., & Kulkarni, S. K. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01422-5 · Cited by 15 · cited 1×
“Likewise, the effects of FG 7142 in several tests of cognitive performance in monkeys and rats were attenuated by administration of typical and atypical antipsychotic drugs (Murphy et al. 1996a, 1996b; Ninan and Kulkarni 1999).”
BackgroundCadenhead, K. S., & BRAFF, D. L. (2000) · Oxford University Press eBooks · doi:10.1093/oso/9780192629937.003.0005 · Cited by 14
Further evidence for a deficit in switching attention in schizophrenia.
Smith, G. L., Large, M., Kavanagh, D. J., et al. (1998) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.107.3.390 · Cited by 10
Cognitive impairments as causes of positive symptoms in schizophrenia
Phillips, M. L., & David, A. S. (2000) · Oxford University Press eBooks · doi:10.1093/oso/9780192629937.003.0011 · Cited by 10
Comparative dopaminergic and muscarinic antagonist activity of clozapine and haloperidol
Sethy, V. H., Ellerbrock, B. R., & Wu, H. (1996) · Life Sciences · doi:10.1016/0024-3205(95)02327-5 · Cited by 9 · cited 2×
“For example, the high antimuscarinic potency of clozapine (Sethy et al. 1996), reflected by the finding that the discriminative stimulus properties of this drug potently generalize to those of atropine and scopolamine (Nielsen 1988), suggests that the increase in ACh release produced by acute administration of atypica…”
BackgroundCrook, J. M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.987.918 · Cited by 9
When Does Amphetamine-Induced Psychosis Become Schizophrenia?
Flaum, M. A., & Schultz, S. K. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.1.2.205 · Cited by 8 · cited 3×
“Grace (1993) proposed that the primary consequence of the defective regulation of NAC DA afferents in schizophrenia is a decrease in tonic DA release associated with an increase in phasic, activityrelated DA release, possibly due in part to reduced local autoinhibitory mechanisms (Grace 1993; Flaum and Schultz 1996; O…”
BackgroundCognitive Alterations as Markers of Vulnerability to Schizophrenia
Spring, B. J. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb22842.x · Cited by 7 · cited 4×
“…said to suffer from ''hypervigilance ,'' studies using standardized CPTs for the assessment of attentional abilities rarely demonstrated the characteristics of the specific attentional impairments of schizophrenia patients (e.g., Nuechterlein and Dawson 1984; Mussgay and Hertwig 1990; Spring 1992).”
BackgroundInfluential[Benzodiazepine monotherapy in acute schizophrenia].
Jaspert, A., & Ebert, D. (1994) · PubMed · Cited by 7
The use of benzodiazepines in schizophrenia: a review
Llorca, P., Wolf, M. A., & Estorges, J. P. (1991) · European Psychiatry · doi:10.1017/s0924933800003849 · Cited by 7 · cited 2×
“…limited by rapid BZR downregulation , several studies demonstrated the usefulness and potency of BZR agonists in exhibiting antipsychotic effects (Llorca et al. 1991; Delini-Stula et al. 1992; ) and relapse (Kirkpatrick et al. 1989), and, when coadministered with typical antipsychotic drugs, in…”
BackgroundPSYCHIATRIC SEQUELÆ OF CHRONIC EXPOSURE TO ORGANOPHOSPHORUS INSECTICIDES
Bicknell, F., & Kitcat, C. D. W. (1961) · The Lancet · doi:10.1016/s0140-6736(61)92688-5 · Cited by 6
Bassareo, V., Tanda, G., Petromilli, P., Giua, C., & Chiara, G. D. (1996) · Psychopharmacology · doi:10.1007/bf02246138 · Cited by 2 · cited 2×
“Furthermore, FG 7142 increases mesolimbic DA efflux (Tam and Roth 1985; Brose et al. 1987; Bradberry et al. 1991; McCullough and Salamone 1992; Bassareo et al. 1996) and, with remarkable efficacy, basal cortical ACh efflux (up to 400% over baseline reported in Moore et al.”
BackgroundFinch (1996) · doi:10.1002/(sici)1098-1063(1996)6:5<495::aid-hipo3>3.0.co;2-i · cited 2×
“Dopaminergic inputs to the NAC, originating in the ventral tegmental area, converge with telencephalic (glutamatergic) projections on medium spiny NAC efferents (Sesack and Pickel 1990; Wu et al. 1993; Taber and Fibiger 1995; Finch 1996; Whitelaw et al. 1996; Blaha et al. 1997; Floresco et al. 1998; Mulder et al. 1998…”
Background
Cited by
The debate over dopamine’s role in reward: the case for incentive salience
Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347
“Clinical implications follow, of course, from any extension of dopamine's role into aversive states (Kapur 2003; Sarter et al. 2005).”
BackgroundDrevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241
“Excessive cortical cholinergic activity in experimental animals results in ‘‘hyperattentive impairments’’ (Sarter et al. 2005), where over activity of the cholinergic system reduces the signal detection threshold and leads to over processing of stimuli.”
BackgroundNeural synchrony in brain disorders: Relevance for cognitive dysfunctions and pathophysiology
Uhlhaas, P. J., & Singer, W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.020 · Cited by 2,194
Abnormal neural oscillations and synchrony in schizophrenia
Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120
“Accordingly, alterations in cholinergic neurotransmission may be relevant for dysfunctions in neural oscillations in schizophreni”
BackgroundModes and models of forebrain cholinergic neuromodulation of cognition
Hasselmo, M. E., & Sarter, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.104 · Cited by 733
“Persistent spiking may contribute to the generation of responses in the sustained attention task (Sarter et al, 2005; McGaughy and Sarter, 1998).”
BackgroundSelf-citation
Metadata
- Authors
- Sarter, M.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Sarter, M.
- ORCID
- Sarter, M.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-01
- Volume
- 31
- Issue
- 1
- Pages
- 117-138
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1707
- OpenAlex
- W2164855564
- Cited by
- 153
- References
- 321
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2020: 3 · 2019: 1 · 2018: 6 · 2017: 2 · 2016: 1 · 2015: 6 · 2014: 4 · 2013: 5 · 2012: 5
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Bulletin (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ohio State University
- National Institute of Mental Health (R01MH063114, R01MH057436, MH57436, MH63114)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- schizophrenia
- MeSH terms
- Acetylcholine, Attention, Mental Disorders, Cerebral Cortex, Cholinergic Fibers, Cognition Disorders, Dopamine, Humans, Nucleus Accumbens, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.